Use of soluble guanylate cyclase activators for treating reperfusion damage
Details for Australian Patent Application No. 2006286896 (hide)
International Classifications
Event Publications
31 January 2008 PCT application entered the National Phase
PCT publication WO2007/025595 Priority application(s): WO2007/025595
14 May 2009 Assignment before Grant
Bayer HealthCare AG The application has been assigned to Bayer Schering Pharma Aktiengesellschaft
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006286897-Pyrazolo [3 , 4-d] azepine derivatives as histamine H3 antagonists
2006286894-Case for accommodating a medicament pack, and use thereof
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser